%PDF-1.4
%
1 0 obj
<>
endobj
177 0 obj
<>stream
Creo Normalizer JTP
2024-03-19T06:14:03-07:00
2007-08-14T11:41:17-04:00
2024-03-19T06:14:03-07:00
uuid:d2269e67-aa99-4212-9c20-dbdaa21ca724
uuid:0041eaca-1dd2-11b2-0a00-b800f869b0ff
application/pdf
endstream
endobj
2 0 obj
<>
endobj
6 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/TrimBox[9.0 9.0 594.0 792.0]/Type/Page>>
endobj
67 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/TrimBox[9.0 9.0 594.0 792.0]/Type/Page>>
endobj
122 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[9.0 9.0 594.0 792.0]/Type/Page>>
endobj
189 0 obj
[194 0 R]
endobj
168 0 obj
<>
endobj
190 0 obj
<>stream
BT
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
10 0 0 10 44.1648 738.8835 Tm
[(Stromal)-333 (Cell-Derived)-332.9 (Factor-1)-332.9 (Induces)-332.9 (Matrix)-332.9 (Metalloprotease-13)-332.9 (Expression)-332.9 (in)-332.9 (Human)-332.9 (Chondrocytes)]TJ
/T1_1 1 Tf
2 -1.2 Td
[(Yung-Cheng)-332.9 (Chiu,)-333 (Rong-Sen)-332.9 (Yang,)-333 (Kuo-Hsien)-332.9 (Hsieh,)-333 (Yi-Chin)-332.9 (Fong,)-333 (Tzong-Der)-333 (Way,)-333 (Tu-Sheng)-332.9 (Lee,)]TJ
0 -1.2 TD
[(Hsi-Chin)-332.9 (Wu,)-333 (Wen-Mei)-333 (Fu,)-333 (and)-332.9 (Chih-Hsin)-332.9 (Tang)]TJ
/T1_0 1 Tf
47.9329 0 Td
(695)Tj
-49.9329 -1.7 Td
[(Low-Dose)-332.9 (BBR3610)-332.9 (Toxicity)-332.9 (in)-332.9 (Colon)-332.9 (Cancer)-332.9 (Cells)-332.9 (Is)-332.9 (p53-Independent)-332.9 (and)-332.9 (Enhanced)-332.9 (by)-333 (Inhibition)-332.9 (of)]TJ
2 -1.2 Td
[(Epidermal)-333 (Growth)-332.9 (Factor)-332.9 (Receptor)-332.9 (\(ERBB1\)-Phosphatidyl)-333 (Inositol)-333 (3)-332.9 (Kinase)-332.9 (Signaling)]TJ
/T1_1 1 Tf
T*
[(Clint)-332.9 (Mitchell,)-332.9 (Peyman)-332.9 (Kabolizadeh,)-332.9 (John)-332.9 (Ryan,)-332.9 (John)-332.9 (D.)-333 (Roberts,)-332.9 (Adly)-332.9 (Yacoub,)-332.9 (David)-332.9 (T.)-333 (Curiel,)]TJ
T*
[(Paul)-332.9 (B.)-332.9 (Fisher,)-332.9 (Michael)-333 (P.)-333 (Hagan,)-333 (Nicholas)-332.9 (P.)-332.9 (Farrell,)-332.9 (Steven)-332.9 (Grant,)-333 (and)-332.9 (Paul)-332.9 (Dent)]TJ
/T1_0 1 Tf
47.9329 0 Td
(704)Tj
-49.9329 -1.7 Td
[(Distinct)-332.9 (Profiles)-332.9 (of)]TJ
/T1_2 1 Tf
10 0 1.554 10 134.8922 644.8835 Tm
(\001)Tj
/T1_0 1 Tf
10 0 0 10 141.0021 644.8835 Tm
[(7)-332.9 (nAChR)-332.9 (Positive)-332.9 (Allosteric)-332.9 (Modulation)-332.9 (Revealed)-332.9 (by)-332.9 (Structurally)-332.9 (Diverse)]TJ
-7.6837 -1.2 Td
(Chemotypes)Tj
/T1_1 1 Tf
T*
[(Jens)-332.9 (Halvard)-332.9 (Gr)]TJ
/T1_0 1 Tf
(\370)Tj
/T1_1 1 Tf
[(nlien,)-333 (Monika)-332.9 (H\345kerud,)-333 (Hilde)-332.9 (Ween,)-332.9 (Kirsten)-332.9 (Thorin-Hagene,)-333 (Clark)-332.9 (A.)-333 (Briggs,)]TJ
T*
[(Murali)-332.9 (Gopalakrishnan,)-332.9 (and)-332.9 (John)-332.9 (Malysz)]TJ
/T1_0 1 Tf
47.9329 0 Td
(715)Tj
-49.9329 -1.7 Td
[(Thiazolidinediones)-332.9 (Modulate)-332.9 (the)-332.9 (Expression)-332.9 (of)]TJ
/T1_2 1 Tf
10 0 1.554 10 266.5493 591.8835 Tm
(\002)Tj
/T1_0 1 Tf
10 0 0 10 272.6593 591.8835 Tm
[(-Catenin)-332.9 (and)-332.9 (Other)-332.9 (Cell-Cycle)-332.9 (Regulatory)-332.9 (Proteins)-332.9 (by)]TJ
-20.8494 -1.2 Td
[(Targeting)-332.9 (the)-332.9 (F-Box)-332.9 (Proteins)-333 (of)-332.9 (Skp1-Cul1-F-box)-332.9 (Protein)-332.9 (E3)-332.9 (Ubiquitin)-332.9 (Ligase)-332.9 (Independently)-332.9 (of)]TJ
T*
[(Peroxisome)-332.9 (Proliferator-Activated)-332.9 (Receptor)]TJ
/T1_2 1 Tf
10 0 1.554 10 269.6904 567.8835 Tm
(\003)Tj
/T1_1 1 Tf
10 0 0 10 64.1648 555.8835 Tm
[(Shuo)-332.9 (Wei,)-333 (Li-Fang)-332.9 (Lin,)-333 (Chih-Cheng)-332.9 (Yang,)-333 (Yu-Chieh)-332.9 (Wang,)-333 (Geen-Dong)-332.9 (Chang,)-333 (Hungwen)-332.9 (Chen,)]TJ
T*
[(and)-332.9 (Ching-Shih)-332.9 (Chen)]TJ
/T1_0 1 Tf
47.9329 0 Td
(725)Tj
-49.9329 -1.7 Td
[(Functional)-332.9 (Characterization)-332.9 (of)-332.9 (the)-332.9 (Promoter)-332.9 (of)-332.9 (Human)-332.9 (Carbonyl)-333 (Reductase)-332.9 (1)-332.9 (\()]TJ
/T1_1 1 Tf
[0.1 (CBR1)]TJ
/T1_0 1 Tf
[(\).)-333 (Role)-332.9 (of)]TJ
/T1_1 1 Tf
44.2898 0 Td
(XRE)Tj
/T1_0 1 Tf
-42.2898 -1.2 Td
[(Elements)-332.9 (in)-332.9 (Mediating)-332.9 (the)-332.9 (Induction)-332.9 (of)]TJ
/T1_1 1 Tf
18.8485 0 Td
(CBR1)Tj
/T1_0 1 Tf
3.0739 0 Td
[(by)-332.9 (Ligands)-332.9 (of)-333 (the)-332.9 (Aryl)-333 (Hydrocarbon)-332.9 (Receptor)]TJ
/T1_1 1 Tf
-21.9224 -1.2 Td
[(Sukhwinder)-332.9 (S.)-332.9 (Lakhman,)-333 (Xiaomin)-332.9 (Chen,)-333 (Vanessa)-332.9 (Gonzalez-Covarrubias,)-333 (Erin)-332.9 (G.)-333 (Schuetz,)-333 (and)]TJ
T*
[(Javier)-332.9 (G.)-332.9 (Blanco)]TJ
/T1_0 1 Tf
47.9329 0 Td
(734)Tj
-49.9329 -1.7 Td
[(Perturbation)-332.9 (of)-332.9 (Dopamine)-332.9 (Metabolism)-332.9 (by)-332.9 (3-Amino-2-\(4)]TJ
/T1_3 1 Tf
[0.1 (\002)]TJ
/T1_0 1 Tf
[(-halophenyl\)propenes)-332.9 (Leads)-332.9 (to)-332.9 (Increased)]TJ
2 -1.2 Td
[(Oxidative)-332.9 (Stress)-332.9 (and)-332.9 (Apoptotic)-332.9 (SH-SY5Y)-332.9 (Cell)-332.9 (Death)]TJ
/T1_1 1 Tf
T*
[(Warren)-332.9 (C.)-333 (Samms,)-333 (Rohan)-332.9 (P.)-333 (Perera,)-333 (D.)-333 (S.)-332.9 (Wimalasena,)-333 (and)-332.9 (K.)-333 (Wimalasena)]TJ
/T1_0 1 Tf
47.9329 0 Td
(744)Tj
-49.9329 -1.7 Td
[(Phosphorylation)-332.9 (of)-332.9 (G)]TJ
/T1_2 1 Tf
10 0 1.554 10 142.8625 432.8835 Tm
(\001)Tj
/T1_0 1 Tf
7.5 0 0 6.5 148.9724 430.6335 Tm
(s)Tj
10 0 0 10 155.7744 432.8835 Tm
[(Influences)-332.9 (Its)-332.9 (Association)-332.9 (with)-332.9 (the)]TJ
/T1_2 1 Tf
10 0 1.554 10 321.6699 432.8835 Tm
(\004)Tj
/T1_0 1 Tf
10 0 0 10 328.3398 432.8835 Tm
[(-Opioid)-332.9 (Receptor)-332.9 (and)-332.9 (Is)-332.9 (Modulated)-332.9 (by)]TJ
-26.4175 -1.2 Td
[(Long-Term)-332.9 (Morphine)-332.9 (Exposure)]TJ
/T1_1 1 Tf
T*
[(Sumita)-332.9 (Chakrabarti)-332.9 (and)-332.9 (Alan)-332.9 (R)-332.9 (Gintzler)]TJ
/T1_0 1 Tf
47.9329 0 Td
(753)Tj
-49.9329 -1.7 Td
[(Nicotine)-332.9 (Glucuronidation)-332.9 (and)-332.9 (the)-332.9 (Human)-332.9 (UDP-Glucuronosyltransferase)-332.9 (UGT2B10)]TJ
/T1_1 1 Tf
2 -1.2 Td
[(Sanna)-332.9 (Kaivosaari,)-332.9 (Pa)453.4 (\250)-120.5 (ivi)-333 (Toivonen,)-333 (Leah)-332.9 (M.)-333 (Hesse,)-332.9 (Mikko)-332.9 (Koskinen,)-333 (Michael)-333 (H.)-333 (Court,)-333 (and)]TJ
T*
[(Moshe)-332.9 (Finel)]TJ
/T1_0 1 Tf
47.9329 0 Td
(761)Tj
/T1_4 1 Tf
8 0 0 8 31.1648 345.8835 Tm
(\001)Tj
/T1_0 1 Tf
6 0 0 6 33.3266 345.8835 Tm
(S)Tj
10 0 0 10 44.1662 345.8835 Tm
[(Signaling)-332.9 (Pathways)-332.9 (Involved)-332.9 (in)-332.9 (Cyclooxygenase-2)-332.9 (Induction)-332.9 (by)-332.9 (Hepatocyte)-332.9 (Growth)-332.9 (Factor)-333 (in)-332.9 (Non\226)]TJ
1.9999 -1.2 Td
[(Small-Cell)-332.9 (Lung)-332.9 (Cancer)]TJ
/T1_1 1 Tf
T*
[(Jill)-332.9 (M.)-333 (Siegfried,)-332.9 (Christopher)-332.9 (T.)-332.9 (Gubish,)-333 (Mary)-332.9 (E.)-332.9 (Rothstein,)-333 (Pierre)-332.9 (E.)-333 (Queiroz)-332.9 (de)-332.9 (Oliveira,)-333 (and)]TJ
T*
[(Laura)-332.9 (P.)-332.9 (Stabile)]TJ
/T1_0 1 Tf
47.9329 0 Td
(769)Tj
-49.9329 -1.7 Td
[(Modulation)-332.9 (of)-333 (Presynaptic)]TJ
/T1_2 1 Tf
10 0 1.554 10 170.6316 292.8835 Tm
(\002)Tj
/T1_0 1 Tf
10 0 0 10 176.7415 292.8835 Tm
[(3-Containing)-332.9 (GABA)]TJ
7.5 0 0 6.5 270.0697 290.6335 Tm
(A)Tj
10 0 0 10 278.8143 292.8835 Tm
[(Receptors)-332.9 (Limits)-332.9 (the)-332.9 (Immobilizing)-333 (Actions)-332.9 (of)]TJ
-21.4649 -1.2 Td
[(GABAergic)-332.9 (Anesthetics)]TJ
/T1_1 1 Tf
T*
[(Christian)-332.9 (Grasshoff,)-333 (Rachel)-332.9 (Jurd,)-332.9 (Uwe)-332.9 (Rudolph,)-332.9 (and)-332.9 (Bernd)-332.9 (Antkowiak)]TJ
/T1_0 1 Tf
47.9329 0 Td
(780)Tj
-49.9329 -1.7 Td
[(The)-332.9 (Multikinase)-332.9 (Inhibitor)-332.9 (Sorafenib)-332.9 (Induces)-332.9 (Apoptosis)-332.9 (in)-332.9 (Highly)-332.9 (Imatinib)-332.9 (Mesylate-Resistant)-333 (Bcr/Abl)]TJ
/T1_3 1 Tf
7.5 0 0 6.5 523.7634 256.1335 Tm
(\001)Tj
/T1_0 1 Tf
10 0 0 10 64.1648 239.8835 Tm
[(Human)-332.9 (Leukemia)-332.9 (Cells)-332.9 (in)-332.9 (Association)-332.9 (with)-332.9 (Signal)-332.9 (Transducer)-332.9 (and)-332.9 (Activator)-332.9 (of)-333 (Transcription)-332.9 (5)]TJ
T*
[(Inhibition)-332.9 (and)-332.9 (Myeloid)-332.9 (Cell)-332.9 (Leukemia-1)-332.9 (Down-Regulation)]TJ
/T1_1 1 Tf
T*
[(Mohamed)-332.9 (Rahmani,)-333 (Tri)-332.9 (K.)-333 (Nguyen,)-333 (Paul)-333 (Dent,)-333 (and)-332.9 (Steven)-332.9 (Grant)]TJ
/T1_0 1 Tf
47.9329 0 Td
(788)Tj
/T1_5 1 Tf
-49.9329 -3.6 Td
(ERRATA)Tj
/T1_0 1 Tf
0 -1 TD
[(Correction)-332.9 (to)-332.9 (\223Chromanol)-333 (293B)-332.9 (Binding)-332.9 (in)-332.9 (KCNO1)-332.9 (\(Kv7.1\))-332.9 (Channels)-332.9 (Involves)-332.9 (Electrostatic)]TJ
2 -1.2 Td
[(Interactions)-332.9 (with)-332.9 (a)-332.9 (Potassium)-332.9 (Ion)-332.9 (in)-332.9 (the)-332.9 (Selectivity)-332.9 (Filter\224)-20304.7 (796)]TJ
-2 -1.7 Td
[(Correction)-332.9 (to)-332.9 (\223)]TJ
/T1_1 1 Tf
[(Phoneutria)-332.9 (nigriventer)]TJ
/T1_0 1 Tf
17.6976 0 Td
[(Toxin)-332.9 (1:)-332.9 (A)-332.9 (Novel,)-332.9 (State-Dependent)-333 (Inhibitor)-332.9 (of)-333 (Neuronal)-333 (Sodium)]TJ
-15.6976 -1.2 Td
[(Channels)-332.9 (That)-332.9 (Interacts)-332.9 (with)]TJ
/T1_2 1 Tf
10 0 1.554 10 206.561 128.8835 Tm
(\004)Tj
/T1_0 1 Tf
10 0 0 10 216.5604 128.8835 Tm
[(Conotoxin)-332.9 (Binding)-332.9 (Sites\224)]TJ
32.6934 0 Td
(797)Tj
/T1_4 1 Tf
9 0 0 9 44.1648 94.3835 Tm
(\001)Tj
/T1_0 1 Tf
7 0 0 7 46.5967 94.3835 Tm
(S)Tj
10 0 0 10 56.0068 94.3835 Tm
[(Supplemental)-332.9 (material)-332.9 (is)-332.9 (available)-332.9 (online)-332.9 (at)-332.9 (http://molpharm.aspetjournals.org.)]TJ
/T1_1 1 Tf
8 0 0 8 59.1648 59.3835 Tm
[(About)-265.6 (the)-265.6 (cover:)]TJ
/T1_0 1 Tf
7.7901 0 Td
[(Docking)-265.6 (of)-265.6 (representative)-265.6 (MANT-)-265.6 (and)-265.6 (TNP)-265.6 (nucleotides)-265.6 (to)-265.6 (CyaA.)-265.6 (See)-265.6 (the)-265.6 (article)-265.6 (by)-265.6 (Go)416.4 (\250)-83.4 (ttle)-265.6 (et)-265.6 (al.)-265.6 (on)-265.6 (page)-265.6 (526)-265.6 (of)-265.6 (this)]TJ
-7.7901 -1.25 Td
(issue.)Tj
ET
/CS0 CS 1 SCN
48.5 w
/GS1 gs
44.165 58.133 m
47.165 58.133 l
S
3 w
47.165 80.884 m
558.165 80.884 l
S
48.5 w
555.165 58.133 m
558.165 58.133 l
S
3 w
44.165 35.383 m
555.165 35.383 l
S
BT
0 g
/GS2 gs
/T1_6 1 Tf
0 -9 9 0 586 386.75706 Tm
( at ASPET Journals on March 19, 2024)Tj
/GS2 gs
-11.22099 0 Td
(molpharm.aspetjournals.org)Tj
/GS2 gs
-7.55399 0 Td
(Downloaded from )Tj
ET
endstream
endobj
153 0 obj
<>
endobj
125 0 obj
<>
endobj
128 0 obj
<>
endobj
131 0 obj
<>
endobj
135 0 obj
<>
endobj
139 0 obj
<>
endobj
144 0 obj
<>
endobj
183 0 obj
<>
endobj
145 0 obj
<>
endobj
146 0 obj
<>stream
Hl{PWw.*F%$B)E#@Tt@>"DP^Q,%jacgjQ㜍wvSpǝ{;.II$,Z=c>o>Ӕc,OIظuCF˫IˍP0\*e }Y_$$$$АU`ܜnLK }?U[C]5,Xjبd۲51)clҧj5MK![s7g"H " %" B$\#n:'גK<$iim%v*87#!N.}P֣XAԁݪܝELshqFE\;#G23)sMC9T>ŕ$Kp@@D
WK
dIB2kǿ| JzR+$+v|QcnNP/aML7Y}3jM2H88
21f/e,Js;G}Y~u%
*ʁSU)>íExK#